Abdulrahman Nasiri: How AI and Deep Learning May Help Reshape the Future of Thalassaemia Care
Abdulrahman Nasiri, Assistant Professor at Imam Muhammad ibn Saud Islamic University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Hemoglobin Journal, adding:
“Some publications feel more personal than others.
Honored to see our article, ‘Beyond Diagnosis: A Systematic Review of Artificial Intelligence and Deep Learning in Monitoring Iron Overload and Organ Toxicity in Beta-Thalassemia,’ published in Hemoglobin Journal alongside International Thalassaemia Day.
Thalassaemia is not defined only by transfusions or laboratory values.
Behind every MRI, ferritin level, and clinic visit is a patient navigating a lifelong journey that demands resilience, consistency, and hope.
This review explored how artificial intelligence and deep learning may help reshape the future of thalassaemia care through:
- Smarter MRI interpretation
- Earlier recognition of cardiac and hepatic toxicity
- More precise monitoring of iron overload
- Better support for personalized clinical decisions
What makes this field exciting is not the technology itself, but what it can mean for patients.
Earlier intervention. Better protection of organs. More informed decisions. Better quality of life.
At the same time, medicine must approach AI responsibly. Innovation without validation has no place in patient care.
The future requires rigorous science, transparency, and collaboration between clinicians, researchers, and data scientists.
Proud to have collaborated on this work with: Dr. Mostafa Faisal Mohammed Saleh, Dr. Manal Alshammari, Dr. Ali Alahmari, Dr. Reem Alkharras, and Prof. Fahad Almohareb and Grateful to everyone worldwide advancing thalassaemia care and research.
Bringing Thal to Light.”
Title: Beyond Diagnosis: A Systematic Review of Artificial Intelligence and Deep Learning in Monitoring Iron Overload and Organ Toxicity in Beta-Thalassemia
Authors: Abdulrahman Nasiri, Mostafa F. Mohammed Saleh, Manal Alshammari, Ali Alahmari, Reem Alkharras, Fahad Almohareb
More posts featuring Abdulrahman Nasiri on Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers